Enrolling By Invitation PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT05897086

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

Nerve Repair Using Hydrophilic Polymers to Improve Tactile and Erogenous Neophallus Sensation

Sponsor: Vanderbilt University Medical Center

Updated 6 times since 2023 Last updated: Oct 16, 2025 Started: Aug 1, 2023 Primary completion: Dec 30, 2028 Completion: Dec 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Gender Dysphoria, this trial is ongoing. The trial is conducted by Vanderbilt University Medical Center and has accumulated 6 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Nov 2025 — Present [monthly]

Enrolling By Invitation PHASE2/PHASE3
Nov 2024 — Nov 2025 [monthly]

Enrolling By Invitation PHASE2/PHASE3
Sep 2024 — Nov 2024 [monthly]

Enrolling By Invitation PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Oct 2023 — Jul 2024 [monthly]

Enrolling By Invitation PHASE2_PHASE3

Status: Recruiting → Enrolling By Invitation

▶ Show 1 earlier version

Jul 2023 — Oct 2023 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University Medical Center

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States